Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Endocrinol. doi: /nrendo

Published byIveta Vávrová Modified over 6 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Endocrinol. doi: /nrendo"— Presentation transcript:

1 Nat. Rev. Endocrinol. doi:10.1038/nrendo.2014.226
Figure 1 Identification of CD34+ fibrocytes in patients with Graves disease and TAO Adapted with minor modifications with permission of Endocrine Society from Douglas, S. et al. Increased generation of fibrocytes in thyroid-associated ophthalmopathy, J. Clin. Endocrinol. Metab. 95, ©2010; permission conveyed through Copyright Clearance Center, Inc. Smith, T. J. (2014) TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy Nat. Rev. Endocrinol. doi: /nrendo

Download ppt "Nat. Rev. Endocrinol. doi: /nrendo"

Similar presentations

(Adapted, with permission, from Fagin JA

(Adapted, with permission, from Fagin JA
Fig. 1. Correlation of TSH with TC, LDL-C, HDL-C, and TG.

Fig. 1. Correlation of TSH with TC, LDL-C, HDL-C, and TG.
Nat Clin Pract Endocrinol Metab 3: 279–289 doi: /ncpendmet0447

Nat Clin Pract Endocrinol Metab 3: 279–289 doi: /ncpendmet0447
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Invest. Ophthalmol. Vis. Sci ;55(3): doi: /iovs Figure Legend:

Invest. Ophthalmol. Vis. Sci ;55(3): doi: /iovs Figure Legend:
Copyright © 2017 American Academy of Pediatrics.

Copyright © 2017 American Academy of Pediatrics.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
HT (n = 45), healthy control subjects (HC) (n = 22), DTC-I, recurrent or persistent DTC (n = 27), DTC-II, disease free DTC (n = 34). Tg clusters are defined.

HT (n = 45), healthy control subjects (HC) (n = 22), DTC-I, recurrent or persistent DTC (n = 27), DTC-II, disease free DTC (n = 34). Tg clusters are defined.
Figure 1. Total (A) and free (B) T, estradiol (C), and SHBG (D) levels at baseline and during treatment. From: Testosterone Treatment and Sexual Function.

Figure 1. Total (A) and free (B) T, estradiol (C), and SHBG (D) levels at baseline and during treatment. From: Testosterone Treatment and Sexual Function.
Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< 0.0001. Decreased Melatonin Levels in Postmortem Cerebrospinal.

Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< Decreased Melatonin Levels in Postmortem Cerebrospinal.
FIG. 1 Odds ratios (95% CIs) of metabolic syndrome and individual components calculated for clinical measures of periodontal disease (A and B). For gingival.

FIG. 1 Odds ratios (95% CIs) of metabolic syndrome and individual components calculated for clinical measures of periodontal disease (A and B). For gingival.
From: Is Age a Risk Factor for Hypothyroidism in Pregnancy

From: Is Age a Risk Factor for Hypothyroidism in Pregnancy
Figure 2 Electromechanical properties of OIHPs

Figure 2 Electromechanical properties of OIHPs
Figure 6 Selected examples of TERS applications in material systems

Figure 6 Selected examples of TERS applications in material systems
Figure 1. Correlations between TNFα and HOMA IR in men (•) and women (○). Circulating Tumor Necrosis Factor-α Concentrations in a Native Canadian Population.

Figure 1. Correlations between TNFα and HOMA IR in men (•) and women (○). Circulating Tumor Necrosis Factor-α Concentrations in a Native Canadian Population.
Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.

Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.
Figure 2 Regions of Africa exposed to undernutrition

Figure 2 Regions of Africa exposed to undernutrition
with undiagnosed diabetes mellitus by three diagnostic criteria

with undiagnosed diabetes mellitus by three diagnostic criteria
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Figure 5 BMI and cardiorespiratory fitness levels

Figure 5 BMI and cardiorespiratory fitness levels

Similar presentations

Ads by Google